Evidence map›Paper›PMID 37589381›Full record

Observational studyeLife2023

Nationwide mammography screening participation in Denmark during the COVID-19 pandemic: An observational study.

Tina Bech Olesen, Henry Jensen, Henrik Møller, Jens Winther Jensen, Berit Andersen, Ilse Vejborg, Sisse H Njor

Abstract readObservational Study
In one paragraph

Observational study in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tina Bech OlesenThe Danish Clinical Quality Program - National Clinical Registries (RKKP), Aarhus N, Denmark.ORCID 0000-0002-6295-7399
Henry JensenThe Danish Clinical Quality Program - National Clinical Registries (RKKP), Aarhus N, Denmark.ORCID 0000-0003-4040-7334
Henrik MøllerThe Danish Clinical Quality Program - National Clinical Registries (RKKP), Aarhus N, Denmark.
Jens Winther JensenThe Danish Clinical Quality Program - National Clinical Registries (RKKP), Aarhus N, Denmark.
Berit AndersenUniversity Research Clinic for Cancer Screening, Department of Public Health Programmes, Randers Regional Hospital, Randers, Denmark.
Ilse VejborgDepartment of Breast Examinations, Copenhagen University Hospital, Copenhagen, Denmark.
Sisse H NjorThe Danish Clinical Quality Program - National Clinical Registries (RKKP), Aarhus N, Denmark.ORCID 0000-0003-0429-4176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In most of the world, the mammography screening programmes were paused at the start of the pandemic, whilst mammography screening continued in Denmark. We examined the mammography screening participation during the COVID-19 pandemic in Denmark. Methods: The study population comprised all women aged 50-69 years old invited to participate in mammography screening from 2016 to 2021 in Denmark based on data from the Danish Quality Database for Mammography Screening in combination with population-based registries. Using a generalised linear model, we estimated prevalence ratios (PRs) and 95% confidence intervals (CIs) of mammography screening participation within 90, 180, and 365 d since invitation during the pandemic in comparison with the previous years adjusting for age, year and month of invitation. Results: The study comprised 1,828,791 invitations among 847,766 women. Before the pandemic, 80.2% of invitations resulted in participation in mammography screening within 90 d, 82.7% within 180 d, and 83.1% within 365 d. At the start of the pandemic, the participation in screening within 90 d was reduced to 69.9% for those invited in pre-lockdown and to 76.5% for those invited in first lockdown. Extending the length of follow-up time to 365 d only a minor overall reduction was observed (PR = 0.94; 95% CI: 0.93-0.95 in pre-lockdown and PR = 0.97; 95% CI: 0.96-0.97 in first lockdown). A lower participation was, however, seen among immigrants and among women with a low income. Conclusions: The short-term participation in mammography screening was reduced at the start of the pandemic, whilst only a minor reduction in the overall participation was observed with longer follow-up time, indicating that women postponed screening. Some groups of women, nonetheless, had a lower participation, indicating that the social inequity in screening participation was exacerbated during the pandemic. Funding: The study was funded by the Danish Cancer Society Scientific Committee (grant number R321-A17417) and the Danish regions.

Indexed as

COVID-19AgedCommunicable Disease ControlDenmarkFemaleHumansMammographyMiddle AgedPandemicsCOVID-19 pandemicepidemiologyglobal healthmammography screening

Identifiers

PMID37589381
PMCPMC10513477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.